Doxorubicin Sandoz

Medicinal product

(Invented) name

Doxorubicin Sandoz

Active substance (s)

Doksorubicino hidrochloridas

Strength

2 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną, vartoti į šlapimo pūslę

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01DB01, Doxorubicin

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-09-10

Date of renewal

Documents

3584_Doxorubicin Sandoz 2mg-ml_konc_inf_PL_2026-09-10.docx

3584_Doxorubicin Sandoz 2mg-ml_konc_inf_PZ_2026-09-10.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml koncentrato yra	1 ml
Doksorubicino hidrochloridas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122254	108366	1108366	flakonas	5 ml N1		Receptinis	LT/L/26/3584/001	Netiekiama	-	-	No	-	-	Download
122255	108367	1108367	flakonas	25 ml N1		Receptinis	LT/L/26/3584/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-09-10	Registruotas